Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Railkar

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|August 26, 2000
Simultaneous testing strategy for comparing two treatments in a stratified binomial trialR A Railkar, D V Mehrotra, B Iglewicz
Clinical and Translational Science|July 21, 2017
Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose SelectionA W Krug, P Vaddady, R A Railkar, et al.
Clinical Pharmacology and Therapeutics|January 15, 2016
An accessible pharmacodynamic transcriptional biomarker for notch target engagementK Q Tanis, A A Podtelezhnikov, S C Blackman, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|August 26, 2000
Simultaneous testing strategy for comparing two treatments in a stratified binomial trialR A Railkar, D V Mehrotra, B Iglewicz
Clinical and Translational Science|July 21, 2017
Leveraging a Clinical Phase Ib Proof-of-Concept Study for the GPR40 Agonist MK-8666 in Patients With Type 2 Diabetes for Model-Informed Phase II Dose SelectionA W Krug, P Vaddady, R A Railkar, et al.
Clinical Pharmacology and Therapeutics|January 15, 2016
An accessible pharmacodynamic transcriptional biomarker for notch target engagementK Q Tanis, A A Podtelezhnikov, S C Blackman, et al.
Pageof 1